Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente study shows computerized interpretation of doctors’ echocardiogram reports can identify patients with aortic stenosis.
Kaiser Permanente study by adjunct investigator and oncologist/hematologist Minggui Pan, MD, PhD, quantifies impact of a virtual tumor board for rare type of cancer.
Kaiser Permanente study finds less use among Black, Hispanic, and Hawaiian/Pacific Islander patients compared to white and Asian patients.
The Association of American Physicians announced it has inducted Kaiser Permanente research scientist and gastroenterologist Douglas Corley, MD, PhD, MPH, into its honorary medical society.
COVID-19 patients who are not hospitalized are at low risk of developing blood clots and should not routinely be prescribed blood thinners, a new Kaiser Permanente research letter suggests.
Kaiser Permanente researchers have developed a more precise way to assess a patient's risk of a heart attack, stroke, or other major heart-related problem within the next 60 days.
Kaiser Permanente research shows the need for increased education about the dangers of high blood pressure.
KP Research Radio speaks with research scientist and gastroenterologist Jeffrey K. Lee, MD, MAS, about the studies that led to Kaiser Permanente’s successful screening program.
Four out of 5 Kaiser Permanente Northern California members who used a simplified online e-visit for a basic health concern did not need follow-up care in the following week, a new analysis finds.
A research team led by Romain S. Neugebauer, PhD, received the award from the Patient-Centered Outcomes Research Institute to compare costs, and benefits and harms of second-line medications.